LOS ANGELES, Oct. 13, 2020 /PRNewswire/ — Scott Yahraus (www.scott4business.com), America’s leading expert in business turnarounds and dispute resolutions, was featured in an article in Business Management News offering strategies to help companies successfully navigate this current economic storm.

In an article titled, “How to Save Your Business During these Challenging Times,” Yahraus offers 7 ways that business owners and senior executives can create an environment that is less susceptible to the merciless impact of the Covid economy.

“America is going through its worst economic times since the Great Depression. Millions are out of work. Thousands of businesses have closed – at least temporarily,” the article stated. “Make sure your business isn’t one of them.”

The first piece of advice Yahraus shares is perhaps the hardest to swallow. “Know when to pull the plug,” he states. “There could be an opportunity for you to merge or acquire a competitor

Read More

Asian manufacturing, led by China and India, is on the upswing as numerous restrictions remain in important U.S. states like California, and the U.K.

Last week’s manufacturing PMI data showed there is a global rebound in activity that continued into September as lockdown restrictions are lifted, primarily in Asia. Manufacturing PMIs have broadly moved higher into expansionary territory globally, and that does include here at home. Improvements in domestic and external demand are the drivers.

Business sentiment in Asia are improving more than they are in any other emerging market, supported by the reopening of India even as the coronavirus case load remains high. Death tolls and

Read More

By Winni Zhou

SHANGHAI, Oct 12 (Reuters)China’s move to cool a rising yuan stands little chance of stopping further gains, international banks say, as the strength of the world’s number two economy and a near-record yield advantage drive big and steady inflows.

Over the weekend, the People’s Bank of China (PBOC) scrapped a requirement for banks to hold a reserve of yuan forward contracts, removing a guard against depreciation and sending the currency down 1% for its steepest drop since March.

Yet an identical move three years ago ultimately proved ineffective, and investors say this time the conditions are even more likely to buoy the yuan, perhaps as far as 6.5 per dollar.

“In all previous instances, the impact of the regulatory change was temporary,” said Eugenia Victorino, head of Asia strategy at Swedish bank SEB in Singapore.

“We continue to expect the yuan to remain on

Read More

Veeva Systems (NYSE: VEEV) today announced that an increasing number of companies are adopting Veeva Vault CDMS to manage their clinical data. More emerging biotechs and global organizations, including a second top 20 pharmaceutical company, are modernizing clinical data management with Vault CDMS and starting studies faster. Vault CDMS has been used in over 100 trials, for studies in all phases and across diverse therapeutic areas.

Vault CDMS is a modern cloud application suite that combines EDC, coding, data cleaning, and reporting. Customers are building study databases in less than four weeks and making mid-study amendments with zero downtime to run the trials they want without technology limitations.

New innovative capabilities such as configuring rules for edit checks and updating reference ranges across all studies reduce manual processes and provide faster, more precise ways of building and managing trial data. Companies can now accelerate trial database builds,

Read More


Dun & Bradstreet Holdings, Inc. (“Dun & Bradstreet” or the “Company”) (NYSE:DNB), a leading global provider of business decisioning data and analytics, through its subsidiary Dun & Bradstreet Holdings BV, today announced that it has entered into a definitive agreement to purchase the outstanding shares of Bisnode Business Information Group AB (“Bisnode”), a leading European data and analytics firm and long-standing member of the Dun & Bradstreet Worldwide Network. The estimated purchase price upon closing is 7.2B SEK or approximately $818 million USD. The transaction is expected to close in January 2021, subject to required regulatory approvals and customary closing conditions.

“We are pleased to bring Bisnode into the Dun & Bradstreet family following a nearly two-decade strategic alliance,” said Anthony Jabbour, Chief Executive Officer at Dun & Bradstreet. “The powerful combination of our data, analytics and innovative solutions, paired with Bisnode’s deep client

Read More

Oct. 7 (UPI) — Mortgage rates in the United States have fallen to new lows and spurred a flurry of applications to refinance, an industry report said Wednesday.

The Mortgage Bankers Association said in its weekly report that interest rates for a 30-year fixed-rate mortgage fell to 3.01% last week. Moreover, refinancing applications rose 8% and are 50% higher than they were last year at this time.

“Mortgage rates declined across the board last week — with most falling to record lows — and borrowers responded,” Joel Kan, MBA associate vice president of economic and industry forecasting, said in a statement. “The refinance index … hit its highest level since mid-August.”

The lower mortgage rates — which have sunk to record levels multiple times in recent months — have not corresponded, however, to a surge in applications from homebuyers.

While those applications are 21% higher year-to-year, they declined by 2%

Read More

The Aberdeen Asia-Pacific Income Fund (NYSEMKT:FAX) is a closed-end fund that invests in Asia-Pacific region bonds and debt securities. While the COVID-19 pandemic has represented a challenging market environment, the fund has been able to overcome significant volatility to return 2% thus far this year. The actively-managed fund currently yields 8.3% distributed monthly, making it a compelling income vehicle. We are bullish on FAX as macro data suggests the Asia-Pacific region is well-positioned to deliver strong economic growth setting up a positive outlook for region bonds. The combination of attractive yields and strong fundamentals makes FAX a good option to diversify investor portfolios with upside on a total return basis.

(Source: finviz.com)

FAX Background

FAX with over $1.2 billion in total assets and an inception date in 1993 is one of the oldest CEFs investing in the region backed by a long-term track record from a credible management team. The

Read More

News Photo by Steve Schulwitz
Alpena Marketplace co-owner Griffin James, left, and Alpena Downtown Development Authority Executive Director Anne Gentry look at some Alpena-themed apparel at the small business on Wednesday. James and Gentry are two of many young people opening businesses or becoming involved in local government in Northeast Michigan.

MOUNTAIN VIEW, Calif.–(BUSINESS WIRE)–Omnicell, Inc. (NASDAQ:OMCL), a leading provider of medication management solutions and adherence tools for health systems and pharmacies, today announced that it has completed the previously announced acquisition of Pharmaceutical Strategies Group’s (PSG) 340B Link business, pursuant to the terms and conditions of an Equity Purchase Agreement. The acquisition adds a comprehensive and differentiated suite of software-enabled services and solutions used by certain eligible hospitals, health systems, clinics, and entities to manage compliance and capture 340B drug cost savings on outpatient prescriptions filled through the eligible entity’s pharmacy or a contracted pharmacy partner.

The federal 340B Drug Pricing Program has provided financial assistance to hospitals serving vulnerable communities for more than 25 years. The program offers drug discounts to support eligible entities, including certain hospitals and other federally qualified health centers, that provide care for the nation’s underinsured and uninsured patients. According to a 2019

Read More

PHILADELPHIA, Sept. 29, 2020 /PRNewswire/ — A panel of eight distinguished leaders in Life Sciences came together for a virtual breakfast roundtable devoted to leading Life Sciences organizations through these unprecedented times. The event was sponsored by Leaders in Life Sciences, led by Timmy Garde, Chief Innovation Leader, LevLane Advertising, Edward Allera, Shareholder, Buchanan, Ingersoll & Rooney PC, and Thomas Goss, PharmD, Senior Vice President, Boston Healthcare Associates. The theme of the discussion revolved largely around how participants’ Leadership has managed their teams through the challenges presented by the COVID-19 pandemic and the shifts they’ve had to make to adapt to the new landscape.

The event featured executives from all areas of the Life Sciences space including therapeutics, institutional, diagnostics, academics, and policy. Attendees included Al Altomari, Chairman and CEO, Agile Therapeutics; Randy Burkholder, VP, Policy and Research, PhRMA; Natalie Cummins, SVP

Read More